Works by Lobello, Kasia


Results: 14
    1
    2
    3
    4
    5

    Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials.

    Published in:
    Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0189-7
    By:
    • Vandenberghe, Rik;
    • Rinne, Juha O.;
    • Boada, Mercè;
    • Sadao Katayama;
    • Scheltens, Philip;
    • Vellas, Bruno;
    • Tuchman, Michael;
    • Gass, Achim;
    • Fiebach, Jochen B.;
    • Hill, Derek;
    • Lobello, Kasia;
    • Li, David;
    • McRae, Tom;
    • Lucas, Prisca;
    • Evans, Iona;
    • Booth, Kevin;
    • Luscan, Gerald;
    • Wyman, Bradley T.;
    • Hua, Lisa;
    • Lingfeng Yang
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14